Elevated GFAP expression is likely involved in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (Palmer and Ousman, 2018). This evidence concerns the gene GFAP and neurodegenerative disease.